1. 1582 Longitudinal study on the impact of patient-reported fatigue on survival in metastatic cancer patients treated with chemotherapy. (September 2015) Authors: Duong, K.; Fabre, E.; Scotte, F.; Medioni, J.; Rance, B.; Bouchouicha, A.; Oudard, S.; Elaidi, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2612 Prognostic value of baseline Neutrophil to Lymphocyte Ratio (NLR) in metastatic Urothelial Carcinomas (mUC) patients (pts) treated with first-line chemotherapy (CT): A large retrospective multicenter study. (September 2015) Authors: Auvray, M.; Elaidi, R.; Ozguroglu, M.; Guven, S.; Gauthier, H.; Culine, S.; Caty, A.; Dujardin, C.; Auclin, E.; Tartour, E.; Oudard, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma. Issue 1 (December 2017) Authors: Jebali, M.; Elaidi, R.; Brizard, M.; Fouque, J.; Takouchop, C.; Sabatier, B.; Oudard, S.; Medioni, J. Journal: BMC cancer Issue: Volume 17:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗